collection
MENU ▼
Read by QxMD icon Read
search

Adult Psychiatric Unit: Schizophrenia

shared collection
71 papers 500 to 1000 followers
By Edwin Kim Resident Physician, Aspiring Addiction Psychiatrist
https://www.readbyqxmd.com/read/27388573/clozapine-v-first-and-second-generation-antipsychotics-in-treatment-refractory-schizophrenia-systematic-review-and-meta-analysis
#1
REVIEW
Dan Siskind, Lara McCartney, Romi Goldschlager, Steve Kisely
BACKGROUND: Although clozapine is the 'gold standard' for treatment-refractory schizophrenia, meta-analyses of clozapine for this condition are lacking. AIMS: We conducted a systematic review and meta-analysis of clozapine treatment for people with treatment-refractory schizophrenia. METHOD: We searched the Cochrane Schizophrenia Group's trial register, PubMed and EMBASE and hand-searched key papers for randomised controlled trials of clozapine for treatment-refractory schizophrenia...
November 2016: British Journal of Psychiatry: the Journal of Mental Science
https://www.readbyqxmd.com/read/26455671/recommendations-for-the-monitoring-of-serum-concentrations-of-antipsychotic-drugs-in-the-treatment-of-schizophrenia
#2
Leonardo V Lopez, John M Kane
No abstract text is available yet for this article.
September 2015: Journal of Clinical Psychiatry
https://www.readbyqxmd.com/read/23165366/efficacy-and-safety-of-second-generation-long-acting-injections-in-schizophrenia-a-meta-analysis-of-randomized-controlled-trials
#3
REVIEW
Paolo Fusar-Poli, Matthew J Kempton, Robert A Rosenheck
The aim of the present article is to test at a meta-analytical level the efficacy and safety of second-generation long-acting antipsychotic injections (SGLAI) in schizophrenia. Thirteen randomized-controlled trials comparing SGLAI with either placebo or oral antipsychotics were included in a quantitative meta-analysis (6313 patients). Efficacy and safety measures as well as demographic and clinical variables were extracted from each publication or obtained directly from authors. Publication bias was assessed with funnel plots and Egger's intercept...
March 2013: International Clinical Psychopharmacology
https://www.readbyqxmd.com/read/26720422/deconstructing-the-psychosis-risk-syndrome-moving-the-field-of-prevention-forward
#4
EDITORIAL
Barbara A Cornblatt, Ricardo E Carrión
No abstract text is available yet for this article.
February 2016: JAMA Psychiatry
https://www.readbyqxmd.com/read/9258854/integrating-substance-abuse-treatment-for-the-seriously-mentally-ill-into-inpatient-psychiatric-treatment
#5
REVIEW
C M Bradizza, P R Stasiewicz
This paper offers guidelines for the assessment and treatment of substance abuse problems in seriously mentally ill persons who are admitted into inpatient psychiatric treatment. This approach has been used successfully by the authors and may be most useful in settings where a specialized dual-diagnosis treatment program is not feasible. The first step consists of identifying potential substance abusers using several sources of information including the patient's record, a brief patient interview, and an interview with the patient's family and caseworker...
March 1997: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/16595355/differing-effects-of-antipsychotic-medications-on-substance-abuse-treatment-patients-with-co-occurring-psychotic-and-substance-abuse-disorders
#6
COMPARATIVE STUDY
Elizabeth B Stuyt, Terrie A Sajbel, Michael H Allen
This retrospective study of patients treated in a ninety-day, inpatient, dual-diagnosis treatment program examined antipsychotic effectiveness in this population using length of stay in treatment and successful program completion as outcome measures. All patients with co-occurring substance dependence and schizophrenia or schizoaffective disorder treated with olanzapine, risperidone, ziprasidone, and typical depot neuroleptics from January 2001 to December 2003 (N = 55) are the subjects of this study. Patients stayed longer in treatment when taking risperidone (82 +/- 19 days) or ziprasidone (74 +/- 21 days) compared with olanzapine (44 +/- 30 days) or typicals (47 +/- 36 days)...
March 2006: American Journal on Addictions
https://www.readbyqxmd.com/read/15643098/adverse-cardiac-effects-associated-with-clozapine
#7
REVIEW
David B Merrill, G William Dec, Donald C Goff
OBJECTIVE: To review the published literature on serious adverse cardiac events associated with the atypical antipsychotic agent, clozapine, and to make recommendations for cardiac assessment of candidates for clozapine treatment and for monitoring of cardiac status after treatment is initiated. DATA SOURCES: We searched the PubMed and MEDLINE databases for articles published from 1970 to 2004 that contain the keywords "clozapine and myocarditis," "clozapine and cardiomyopathy," "clozapine and cardiotoxicity," "clozapine and sudden death" or "clozapine and mortality...
February 2005: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/23842012/termination-of-clozapine-treatment-due-to-medical-reasons-when-is-it-warranted-and-how-can-it-be-avoided
#8
REVIEW
Jimmi Nielsen, Christoph U Correll, Peter Manu, John M Kane
OBJECTIVE: To identify the outcome of potentially serious adverse effects of clozapine, particularly those frequently cited as reasons for clozapine discontinuation, and to characterize management strategies for adverse effects that do not warrant discontinuation. DATA SOURCES: A structured search was performed of PubMed and EMBASE from database inception until September 10, 2012, without any language restrictions, using clozapine as the search term. Reference lists of retrieved articles were cross-checked for additional relevant studies...
June 2013: Journal of Clinical Psychiatry
https://www.readbyqxmd.com/read/26417473/psychopathology-in-substance-use-disorder-patients-with-and-without-substance-induced-psychosis
#9
Simon Zhornitsky, Andràs Tikàsz, Élie Rizkallah, Jean-Pierre Chiasson, Stéphane Potvin
Background. Substance-induced psychotic disorder (SIPD) is a diagnosis constructed to distinguish substance-induced psychotic states from primary psychotic disorders. A number of studies have compared SIPD persons with primary psychotic patients, but there is little data on what differentiates substance use disorder (SUD) individuals with and without SIPD. Here, we compared psychopathology, sociodemographic variables, and substance use characteristics between SUD patients with and without SIPD. Methods. A retrospective chart review was conducted on newly admitted patients at a rehabilitation centre between 2007 and 2012...
2015: Journal of Addiction
https://www.readbyqxmd.com/read/26541815/comparative-effectiveness-of-clozapine-and-standard-antipsychotic-treatment-in-adults-with-schizophrenia
#10
COMPARATIVE STUDY
T Scott Stroup, Tobias Gerhard, Stephen Crystal, Cecilia Huang, Mark Olfson
OBJECTIVE: The authors compared the effectiveness of initiating treatment with either clozapine or a standard antipsychotic among adults with evidence of treatment-resistant schizophrenia in routine clinical practice. METHOD: U.S. national Medicaid data from 2001 to 2009 were used to examine treatment outcomes in a cohort of patients with schizophrenia and evidence of treatment resistance that initiated clozapine (N=3,123) and in a propensity score-matched cohort that initiated a standard antipsychotic (N=3,123)...
February 1, 2016: American Journal of Psychiatry
https://www.readbyqxmd.com/read/26521019/treatment-of-early-non-response-in-patients-with-schizophrenia-assessing-the-efficacy-of-antipsychotic-dose-escalation
#11
RANDOMIZED CONTROLLED TRIAL
Antony Loebel, Leslie Citrome, Christoph U Correll, Jane Xu, Josephine Cucchiaro, John M Kane
BACKGROUND: Early non-response to antipsychotic treatment in patients with schizophrenia has been shown in multiple studies to predict poor response at short-term trial endpoint. Therefore, strategies to address the challenge of non-improvement early in the course of treatment are needed. A novel trial design was developed to assess the potential utility of antipsychotic dose escalation in patients with an inadequate initial treatment response. This design was embedded in a study intended to assess the efficacy of low dose lurasidone in patients with schizophrenia...
October 31, 2015: BMC Psychiatry
https://www.readbyqxmd.com/read/26481175/raise-ing-our-expectations-for-first-episode-psychosis
#12
EDITORIAL
Thomas R Insel
No abstract text is available yet for this article.
April 1, 2016: American Journal of Psychiatry
https://www.readbyqxmd.com/read/26417330/clinical-pharmacology-of-atypical-antipsychotics-an-update
#13
REVIEW
M C Mauri, S Paletta, M Maffini, A Colasanti, F Dragogna, C Di Pace, A C Altamura
This review will concentrate on the clinical pharmacology, in particular pharmacodynamic data, related to atypical antipsychotics, clozapine, risperidone, paliperidone, olanzapine, que¬tiapine, amisulpride, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone and cariprazine. A summary of their acute pharmacokinetics properties are also reported. Four new second-generation antipsychotics are available: iloperidone, asenapine, lurasidone and in the next future cariprazine. Similar to ziprasidone and aripiprazole, these new agents are advisable for the lower propensity to give weight gain and metabolic abnormalities in comparison with older second-generation antipsychotics such as olanzapine or clozapine...
2014: EXCLI journal
https://www.readbyqxmd.com/read/26302441/long-acting-injectable-vs-oral-risperidone-for-schizophrenia-and-co-occurring-alcohol-use-disorder-a-randomized-trial
#14
RANDOMIZED CONTROLLED TRIAL
Alan I Green, Mary F Brunette, Ree Dawson, Peter Buckley, Amy E Wallace, Hisham Hafez, Marvin Herz, Meera Narasimhan, Douglas L Noordsy, Christopher O'Keefe, Roger W Sommi, Richard M Steinbook, Marjorie Weeks
OBJECTIVE: Alcohol use disorders worsen the course of schizophrenia. Although the atypical antipsychotic clozapine appears to decrease alcohol use in schizophrenia, risperidone does not. We have proposed that risperidone's relatively potent dopamine D2 receptor blockade may partly underlie its lack of effect on alcohol use. Since long-acting injectable (LAI) risperidone both results in lower average steady-state plasma concentrations than oral risperidone (with lower D2 receptor occupancy) and encourages adherence, it may be more likely to decrease heavy alcohol use (days per week of drinking 5 or more drinks per day) than oral risperidone...
October 2015: Journal of Clinical Psychiatry
https://www.readbyqxmd.com/read/26403538/clinical-benefits-and-impact-of-early-use-of-long-acting-injectable-antipsychotics-for-schizophrenia
#15
REVIEW
Georgia L Stevens, Gail Dawson, Jacqueline Zummo
AIM: Results from clinical trials support the use of oral antipsychotics for treatment of early or first-episode psychosis in patients with schizophrenia. This paper will review literature on the advantages of early initiation of treatment for schizophrenia and the clinical benefits of early use of long-acting injectable antipsychotics (LAIs). METHOD: A comprehensive literature review was conducted to identify published literature on the use of LAIs early in the treatment of schizophrenia...
October 2016: Early Intervention in Psychiatry
https://www.readbyqxmd.com/read/26441156/reproductive-safety-of-second-generation-antipsychotics-current-data-from-the-massachusetts-general-hospital-national-pregnancy-registry-for-atypical-antipsychotics
#16
Lee S Cohen, Adele C Viguera, Kathryn A McInerney, Marlene P Freeman, Alexandra Z Sosinsky, Danna Moustafa, Samantha P Marfurt, Molly A Kwiatkowski, Shannon K Murphy, Adriann M Farrell, David Chitayat, Sonia Hernández-Díaz
OBJECTIVE: Second-generation antipsychotics are used to treat a spectrum of psychiatric illnesses in reproductive-age women. The National Pregnancy Registry for Atypical Antipsychotics was established to determine the risk of major malformations among infants exposed to second-generation antipsychotics during pregnancy relative to a comparison group of unexposed infants of mothers with histories of psychiatric morbidity. METHOD: Women were prospectively followed during pregnancy and the postpartum period; obstetric, labor, delivery, and pediatric medical records were obtained...
March 1, 2016: American Journal of Psychiatry
https://www.readbyqxmd.com/read/26205327/skating-on-thin-ice-pragmatic-prescribing-for-medication-refractory-schizophrenia
#17
Derek K Tracy, Dan W Joyce, S Neil Sarkar, Maria-Jesus Mateos Fernandez, Sukhwinder S Shergill
BACKGROUND: Clozapine is the treatment of choice for medication refractory psychosis, but it does not benefit half of those put on it. There are numerous studies of potential post-clozapine strategies, but little data to guide the order of such treatment in this common clinical challenge. We describe a naturalistic observational study in 153 patients treated by a specialist psychosis service to identify optimal pharmacotherapy practice, based on outcomes. METHODS: Medication and clinical data, based on the OPCRIT tool, were examined on admission and discharge from the national psychosis service...
July 25, 2015: BMC Psychiatry
https://www.readbyqxmd.com/read/26008883/dose-escalation-of-antipsychotic-drugs-in-schizophrenia-a-meta-analysis-of-randomized-controlled-trials
#18
Markus Dold, Gernot Fugger, Martin Aigner, Rupert Lanzenberger, Siegfried Kasper
BACKGROUND: Non-response to an initial antipsychotic trial emerges frequently in the pharmacological management of schizophrenia. Increasing the dose (high-dose treatment, dose escalation) is an often applied strategy in this regard, but there are currently no meta-analytic data available to ascertain the evidence of this treatment option. METHODS: We systematically searched for all randomized controlled trials (RCTs) that compared a dose increase directly to the continuation of standard-dose medication in patients with initial non-response to a prospective standard-dose pharmacotherapy with the same antipsychotic compound...
August 2015: Schizophrenia Research
https://www.readbyqxmd.com/read/25727537/outcomes-of-nontransitioned-cases-in-a-sample-at-ultra-high-risk-for-psychosis
#19
Ashleigh Lin, Stephen J Wood, Barnaby Nelson, Amanda Beavan, Patrick McGorry, Alison R Yung
OBJECTIVE: Two-thirds of individuals identified as at ultra-high risk for psychosis do not develop psychotic disorder over the medium term. The authors examined outcomes in a group of such patients. METHOD: Participants were help-seeking individuals identified as being at ultra-high risk for psychosis 2-14 years previously. The 226 participants (125 female, 101 male) completed a follow-up assessment and had not developed psychosis. Their mean age at follow-up was 25...
March 1, 2015: American Journal of Psychiatry
https://www.readbyqxmd.com/read/26107752/long-acting-injectable-risperidone-for-relapse-prevention-and-control-of-breakthrough-symptoms-after-a-recent-first-episode-of-schizophrenia-a-randomized-clinical-trial
#20
RANDOMIZED CONTROLLED TRIAL
Kenneth L Subotnik, Laurie R Casaus, Joseph Ventura, John S Luo, Gerhard S Hellemann, Denise Gretchen-Doorly, Stephen Marder, Keith H Nuechterlein
IMPORTANCE: Long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with schizophrenia. However, long-acting medications are rarely used following a first episode of schizophrenia. OBJECTIVE: To compare the clinical efficacy of the long-acting injectable formulation of risperidone with the oral formulation in the early course of schizophrenia. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial performed at a university-based research clinic, between 2005 and 2012...
August 2015: JAMA Psychiatry
label_collection
label_collection
2575
1
2
2015-06-29 18:06:09
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"